14-day Premium Trial Subscription Try For FreeGet Free
$1.95
+0 (+0%)
At Close: Apr 18, 2023
Chart & Forecast Insider Trading Signals Historical Prices Predictions News Profile

Forward Pharma Reports Q4 Adj. EPS $(0.25) vs $(0.30) Est.

 12:00am, Tuesday, 18'th Apr 2017

Earnings Scheduled For April 10, 2017

 10:50am, Monday, 10'th Apr 2017

JMP Securities Downgrades Forward Pharma to Market Perform

 12:00am, Monday, 03'rd Apr 2017

Acorda Issues Press Release Confirming US District Court Decision to Invalidate 4 AMPYRA Patents, Says Co. Will Appeal Ruling

 12:00am, Friday, 31'st Mar 2017

Court Victory Benefits Biogen And Its Tecfidera Rival Alike

 12:00am, Wednesday, 22'nd Mar 2017

Biogen victory makes company more attractive M&A target - RBC

 12:00am, Tuesday, 21'st Mar 2017

Leerink Presents: Your 2017 Biopharma Catalyst Tracker

 12:00am, Monday, 20'th Mar 2017

Forward Pharma Names Claus Bo Svendsen CEO, Plans To Reorganize and Reduce Burn Rate Following Biogen Settlement

 12:00am, Wednesday, 01'st Mar 2017

Couldn't Make It To Leerink's Global Healthcare Conference? Here Are The Highlights From Day One

 12:00am, Thursday, 16'th Feb 2017

Forward Pharma Reports Received $1.25B Pursuant to Settlement, License Deal with Biogen

 12:00am, Thursday, 09'th Feb 2017

Forward shareholders back $1.25B settlement with Biogen related to Tecfidera patent

 12:00am, Wednesday, 01'st Feb 2017

Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

 12:00am, Wednesday, 18'th Jan 2017

Forward Pharma Reports Deal to Settle, License with Biogen; Biogen Will Pay Forward Non-Refundable Cash Fee of $1.25B

 12:00am, Tuesday, 17'th Jan 2017

Reassessing Biogen

 12:00am, Wednesday, 21'st Dec 2016

Biogen Names Insider New CEO After Five-Month Search, Stock Falls

 12:00am, Monday, 19'th Dec 2016
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE